Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Cannabics Pharmaceuticals Received a New Research License for Characterization of Anti-Tumor Activity of Cannabinoids
Wednesday, November 29, 2017Cannabics Pharmaceuticals Inc CNBX announced today that it has received a new research license from the Israeli Ministry of Health for the Characterization of antitumor activity of cannabinoids The new license will enable the company to continue o...
Titan Pharmaceuticals Partners With Molteni To Market Probuphine® In Europe
Wednesday, November 29, 2017Titan Pharmaceuticals Inc a company developing proprietary therapeutics for the treatment of select chronic diseases utilizing its ProNeura longterm continuous drug delivery technology today announced that it has entered into a binding term sheet wit...
Sobi™ Receives Approval from Health Canada for Orfadin® (nitisinone) Oral Suspension for the Treatment of HT-1
Tuesday, November 28, 2017Sobi a pioneering international biopharmaceutical company dedicated to rare and difficulttotreat diseases has received approval from Health Canada for an oral suspension formulation of Orfadin nitisinone Orfadin is the first medicine approved in mult...
Biogen and Alkermes Announce License and Collaboration Agreement to Develop and Commercialize ALKS 8700
Tuesday, November 28, 2017Biogen and Alkermes plc announced that they have entered into a global license and collaboration agreement to develop and commercialize ALKS a novel oral monomethyl fumarate MMF small drug molecule in Phase development for the treatment of relapsin...
Regeneron Provides Update on EYLEA® (aflibercept) Injection and Nesvacumab (Ang2 Antibody) Combination Program
Monday, November 27, 2017Regeneron Pharmaceuticals Inc announced that results from two Phase studies that added the angiopoietin Ang antibody nesvacumab to EYLEA aflibercept Injection did not provide sufficient differentiation to warrant Phase development The RUBY study ev...
FDA Renews and Expands its Portfolio of Simcyp Simulator (PBPK) Licenses
Monday, November 27, 2017Certara the global leader in modelinformed drug development and regulatory science today announced that the US Food and Drug Administration FDA has greatly expanded its use of Certaras PBPK Simcyp Populationbased Simulator and its Pediatric and Cardi...
KMT Hepatech Announces Strategic Investment From PhoenixBio
Friday, November 24, 2017KMT Hepatech Inc announced that it has reached an agreement to join efforts with PhoenixBio Co Ltd PhoenixBio Together they will advance the use of the cDNAuPASCID mouse model with highly humanized liver to support researchers across a wide range of...
Orig3n™ Acquires Interleukin Genetics
Thursday, November 23, 2017Orign Inc a Boston based biotech company pioneering the future of health through genetics and regenerative medicine research today announced the acquisition of Interleukin Genetics CLIA laboratory and their remaining assets Interleukin Genetics techn...
Puma Biotechnology and Specialised Therapeutics Asia Enter into Exclusive Licensing Agreement to Commercialize NERLYNX® (neratinib)
Thursday, November 23, 2017Puma Biotechnology Inc a biopharmaceutical company and Specialised Therapeutics Asia an international biopharmaceutical company with strategic focus and expertise in Australia New Zealand and South East Asia have entered into an exclusive agreement u...
Fresenius Kabi to Expand Pharmaceutical Manufacturing in North Carolina
Wednesday, November 22, 2017Fresenius Kabi a global health care company that specializes in medicines and technologies for infusion transfusion and clinical nutrition will expand its manufacturing operations in Wilson County Governor Roy Cooper announced today The expansion pro...
